iShares MSCI World ETF Braces for a Transformative Summer

Strong bank profits boost the iShares MSCI World ETF, but looming index changes, SpaceX's IPO, and new US drug tariffs create major portfolio headwinds and opportunities.

A potent mix of stellar bank earnings and looming structural shifts is setting the stage for a pivotal period for the iShares MSCI World ETF. While robust financial sector profits are providing immediate momentum, investors are looking ahead to a major index overhaul in May and the potential market debut of SpaceX, events that could significantly reshape the fund's portfolio composition.

The first-quarter earnings season delivered a powerful boost, particularly from the financial sector, which constitutes approximately 16% of the ETF's holdings. Morgan Stanley capped off the reporting period with a 29% surge in profit to $5.57 billion, while its revenue surpassed $20 billion for the first time. This performance followed strong showings from JPMorgan Chase and Goldman Sachs. Morgan Stanley's equities trading revenue jumped 25% to a record $5.15 billion, and its investment banking revenue grew 36% to $2.12 billion. This strength has analysts forecasting a sixth consecutive quarter of double-digit earnings growth for the S&P 500, the longest such streak in over a decade, though FactSet has slightly revised its Q1 growth estimate to 12.5%.

However, this tailwind is counterbalanced by significant headwinds. The healthcare sector, representing 9.45% of the portfolio, faces a new threat from US tariffs on imported pharmaceutical products set to take effect at the end of July 2026. Imports from the EU, Japan, South Korea, and Switzerland will face a 15% levy, which could skyrocket to 100% for firms without US pricing agreements. Analysts warn these measures could severely pressure margins and potentially boost global inflation by around half a percentage point. US inflation already reached 3.3% in March, its highest level since May 2024, making a Federal Reserve rate cut this year appear unlikely; traders currently price in just a 25% chance.

Simultaneously, BlackRock, the ETF's provider, is confronting intense fee competition. Rival Invesco slashed the expense ratio on its MSCI World ETF to 0.05% on April 1. The iShares fund, with a fee of 0.24%, is now 19 basis points more expensive than the cheapest competitor. In defense, BlackRock highlights its fund's extremely low tracking difference of just 0.02%. This argument appears to hold weight with some major institutions; the Royal Bank of Canada increased its position by 17.5% in Q4 2025, bringing its holding to roughly two million shares.

The most immediate catalyst for change is an index methodology reform scheduled for May. MSCI will introduce a new free-float classification system with three categories, which market observers expect to trigger far more substantial portfolio reshuffling than the modest first-quarter review, which saw 18 additions and 27 deletions. MSCI acquired data specialist PM Insights specifically to enable more precise company valuations under this new system.

Looking further ahead, a potential seismic event looms in June with the anticipated Nasdaq listing of SpaceX. The company is targeting a valuation of $1.75 trillion and aims to raise $75 billion, with a roadshow slated to begin the week of June 8. Should SpaceX meet the inclusion criteria, index-tracking funds like the iShares MSCI World ETF would be required to buy the stock. MSCI anticipates this would increase the index's US weighting and cause noticeable shifts toward application software and aerospace sectors.

Investors have a key date circled on the calendar: June 15, 2026, is the fund's ex-dividend date. By that time, the market will have digested the May index reform and potentially the SpaceX IPO roadshow, revealing how well the ETF's current strengths can buffer against these profound structural changes.